ADPT Adaptive Biotechnologies Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: ADPT

Price (delayed)

$4.51

Market cap

$664.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.49

Enterprise value

$818.47M

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Adaptive Biotechnologies believes the ...

Highlights
ADPT's debt is down by 2% year-on-year
The gross profit has declined by 18% year-on-year but it has grown by 5% since the previous quarter
The gross margin has declined by 13% year-on-year but it is up by 2.7% since the previous quarter
ADPT's equity is down by 35% year-on-year and by 11% since the previous quarter
The quick ratio has declined by 19% year-on-year and by 3% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.adaptivebiotech.com
Peers: CYH PINC SEM HCA

Key stats

What are the main financial stats of ADPT
Market
Shares outstanding
147.37M
Market cap
$664.63M
Enterprise value
$818.47M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.38
Price to sales (P/S)
3.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.69
Earnings
Revenue
$174.5M
EBIT
-$201.8M
EBITDA
-$173.29M
Free cash flow
-$144.81M
Per share
EPS
-$1.49
Free cash flow per share
-$0.99
Book value per share
$1.89
Revenue per share
$1.2
TBVPS
$3.41
Balance sheet
Total assets
$620.32M
Total liabilities
$345.56M
Debt
$228.04M
Equity
$274.91M
Working capital
$291.08M
Liquidity
Debt to equity
0.83
Current ratio
4.51
Quick ratio
4.27
Net debt/EBITDA
-0.89
Margins
EBITDA margin
-99.3%
Gross margin
57.1%
Net margin
-123.2%
Operating margin
-125.3%
Efficiency
Return on assets
-31.1%
Return on equity
-64.1%
Return on invested capital
-32.5%
Return on capital employed
-37.6%
Return on sales
-115.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADPT stock price

How has the Adaptive Biotechnologies stock price performed over time
Intraday
4.16%
1 week
11.63%
1 month
32.26%
1 year
-44.04%
YTD
-7.96%
QTD
24.59%

Financial performance

How have Adaptive Biotechnologies's revenue and profit performed over time
Revenue
$174.5M
Gross profit
$99.58M
Operating income
-$218.6M
Net income
-$215.06M
Gross margin
57.1%
Net margin
-123.2%
Adaptive Biotechnologies's operating margin has decreased by 19% YoY but it has increased by 6% QoQ
The gross profit has declined by 18% year-on-year but it has grown by 5% since the previous quarter
ADPT's net margin is down by 16% year-on-year but it is up by 7% since the previous quarter
The gross margin has declined by 13% year-on-year but it is up by 2.7% since the previous quarter

Growth

What is Adaptive Biotechnologies's growth rate over time

Valuation

What is Adaptive Biotechnologies stock price valuation
P/E
N/A
P/B
2.38
P/S
3.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.69
ADPT's EPS is down by 9% year-on-year but it is up by 4.5% since the previous quarter
ADPT's P/B is 58% below its 5-year quarterly average of 5.4 but 4.1% above its last 4 quarters average of 2.2
ADPT's equity is down by 35% year-on-year and by 11% since the previous quarter
ADPT's price to sales (P/S) is 87% lower than its 5-year quarterly average of 28.0 and 12% lower than its last 4 quarters average of 4.1
The revenue has contracted by 5% YoY but it has grown by 2.5% from the previous quarter

Efficiency

How efficient is Adaptive Biotechnologies business performance
The ROE has shrunk by 56% YoY and by 6% QoQ
Adaptive Biotechnologies's ROA has decreased by 33% YoY
The ROIC has contracted by 19% YoY
ADPT's return on sales is down by 14% year-on-year but it is up by 7% since the previous quarter

Dividends

What is ADPT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADPT.

Financial health

How did Adaptive Biotechnologies financials performed over time
The total assets is 80% more than the total liabilities
The total assets has contracted by 22% YoY and by 6% from the previous quarter
The quick ratio has declined by 19% year-on-year and by 3% since the previous quarter
ADPT's debt is 17% smaller than its equity
ADPT's debt to equity has surged by 51% year-on-year and by 12% since the previous quarter
ADPT's equity is down by 35% year-on-year and by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.